Fidelity Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.65B | Buy |
|
|||||
|
2025
Q2 | $5.15B | Buy |
|
|||||
|
2025
Q1 | $4.13B | Buy |
|
|||||
|
2024
Q4 | $3.17B | Sell |
|
|||||
|
2024
Q3 | $4.04B | Buy |
|
|||||
|
2024
Q2 | $2.96B | Buy |
|
|||||
|
2024
Q1 | $1.49B | Sell |
|
|||||
|
2023
Q4 | $1.97B | Sell |
|
|||||
|
2023
Q3 | $2B | Sell |
|
|||||
|
2023
Q2 | $2.37B | Sell |
|
|||||
|
2023
Q1 | $2.64B | Sell |
|
|||||
|
2022
Q4 | $3.21B | Buy |
|
|||||
|
2022
Q3 | $2.59B | Sell |
|
|||||
|
2022
Q2 | $2.09B | Sell |
|
|||||
|
2022
Q1 | $2.62B | Sell |
|
|||||
|
2021
Q4 | $3.04B | Buy |
|
|||||
|
2021
Q3 | $3.37B | Buy |
|
|||||
|
2021
Q2 | $2.99B | Buy |
|
|||||
|
2021
Q1 | $2.48B | Buy |
|
|||||
|
2020
Q4 | $2.09B | Sell |
|
|||||
|
2020
Q3 | $2.4B | Sell |
|
|||||
|
2020
Q2 | $2.53B | Buy |
|
|||||
|
2020
Q1 | $1.83B | Buy |
|
|||||
|
2019
Q4 | $1.93B | Buy |
|
|||||
|
2019
Q3 | $1.34B | Buy |
|
|||||
|
2019
Q2 | $1.16B | Buy |
|
|||||
|
2019
Q1 | $1.49B | Buy |
|
|||||
|
2018
Q4 | $1.1B | Buy |
|
|||||
|
2018
Q3 | $1.32B | Buy |
|
|||||
|
2018
Q2 | $1.49B | Buy |
|
|||||
|
2018
Q1 | $1.79B | Buy |
|
|||||
|
2017
Q4 | $1.89B | Buy |
|
|||||
|
2017
Q3 | $1.62B | Buy |
|
|||||
|
2017
Q2 | $1.09B | Buy |
|
|||||
|
2017
Q1 | $662M | Buy |
|
|||||
|
2016
Q4 | $482M | Buy |
|
|||||
|
2016
Q3 | $872M | Buy |
|
|||||
|
2016
Q2 | $712M | Buy |
|
|||||
|
2016
Q1 | $804M | Buy |
|
|||||
|
2015
Q4 | $1.2B | Buy |
|
|||||
|
2015
Q3 | $1.02B | Buy |
|
|||||
|
2015
Q2 | $1.52B | Buy |
|
|||||
|
2015
Q1 | $1.31B | Buy |
|
|||||
|
2014
Q4 | $1.12B | Buy |
|
|||||
|
2014
Q3 | $894M | Buy |
|
|||||
|
2014
Q2 | $716M | Buy |
|
|||||
|
2014
Q1 | $644M | Buy |
|
|||||
|
2013
Q4 | $612M | Buy |
|
|||||
|
2013
Q3 | $604M | Buy |
|
|||||
|
2013
Q2 | $289M | Buy |
|